Dataset: Deciphering genomic alterations in colorectal cancer through transcriptional subtype-based network analysis
[u'High-throughput genomic studies have identified thousands of genetic alterations in colorectal cancer (CRC). Distinguishing driver...
[u'High-throughput genomic studies have identified thousands of genetic alterations in colorectal cancer (CRC). Distinguishing driver from passenger mutations is critical for developing rational therapeutic strategies. Because only a few transcriptional subtypes exist in previously studied tumor types, we hypothesize that highly heterogeneous genomic alterations may converge to a limited number of distinct mechanisms that drive unique gene expression patterns in different transcriptional subtypes. In this study, we defined transcriptional subtypes for CRC and identified driver networks/pathways for each subtype, respectively. Applying consensus clustering to a patient cohort with 1173 samples identified three transcriptional subtypes, which were validated in an independent cohort with 485 samples. The three subtypes were characterized by different transcriptional programs related to normal adult colon, early colon embryonic development, and epithelial mesenchymal transition, respectively. They also showed statistically different clinical outcomes. For each subtype, we mapped somatic mutation and copy number variation data onto an integrated signaling network and identified subtype-specific driver networks using a random walk-based strategy. We found that genomic alterations in the Wnt signaling pathway were common among all three subtypes; however, unique combinations of pathway alterations including Wnt, VEGF, Notch and TGF-beta drove distinct molecular and clinical phenotypes in different CRC subtypes. Our results provide a coherent and integrated picture of human CRC that links genomic alterations to molecular and clinical consequences, and which provides insights for the development of personalized therapeutic strategies for different CRC subtypes. To characterize the embryonic development of colon, we conducted a time course microarray study using the inbred C57BL/6 (Jackson Laboratories, Bar Harbor, ME) mice. Seven samples corresponding to the mouse colonic development from E13.5 to E18.5 and adult (eight week post-natal) were collected. RNA samples were submitted to the Vanderbilt Functional Genomics Shared Resource (FSGR, ', {u'a': {u'href': u'http://array.mc.vanderbilt.edu', u'target': u'_blank', u'$': u'http://array.mc.vanderbilt.edu'}}, u'), where RNA was hybridized to the Affymetrix Mouse Genome 430 2.0 GeneChip Expression Arrays (Santa Clara, CA) according to manufacturer\u2019s instructions. The RMA algorithm was used for data normalization. Mouse gene symbols were mapped to human gene symbols by the Human and Mouse Orthology list available from the Mouse Genome Informatics (', {u'a': {u'href': u'http://www.informatics.jax.org/', u'target': u'_blank', u'$': u'http://www.informatics.jax.org/'}}, u').']
- Species:
- mouse
- Samples:
- 7
- Source:
- E-GEOD-38831
- PubMed:
- 24260186
- Updated:
- Dec.12, 2014
- Registered:
- Nov.12, 2014
Sample | DEVELOPMENTAL STAGE |
---|---|
GSM950404 | embryonic day 13.5 |
GSM950405 | embryonic day 14.5 |
GSM950406 | embryonic day 15.5 |
GSM950407 | embryonic day 16.5 |
GSM950408 | embryonic day 17.5 |
GSM950409 | embryonic day 18.5 |
GSM950410 | adult (eight week post-natal) |